Kiniksa Pharmaceuticals International, plc Payments to Acquire Short-term Investments
Kiniksa Pharmaceuticals International, plc (KNSA) reported Payments to Acquire Short-term Investments of $177.41 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-04-28
- Kiniksa Pharmaceuticals International, plc payments to acquire short-term investments for the quarter ending 2026-03-31 was $177.41M, a 85.83% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc payments to acquire short-term investments for the quarter ending 2025-12-31 was $110.96M, a 404.51% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc payments to acquire short-term investments for the quarter ending 2025-09-30 was $146.16M, a 168.28% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc payments to acquire short-term investments for the quarter ending 2025-06-30 was $34.32M, a 61.55% decline year-over-year.
- Kiniksa Pharmaceuticals International, plc payments to acquire short-term investments for fiscal 2025 was $386.92M, a 91.53% increase from fiscal 2024.
- Kiniksa Pharmaceuticals International, plc payments to acquire short-term investments for fiscal 2024 was $202.01M, a 1.42% decline from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc payments to acquire short-term investments for fiscal 2023 was $204.93M, a 50.84% increase from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc payments to acquire short-term investments for fiscal 2022 was $135.86M, a 13.60% decline from fiscal 2021.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2026-03-31 | $177.41M 10-Q · filed 2026-04-28 | $288.37M derived: sum of 2 quarters · filed 2026-04-28 | $434.53M derived: sum of 3 quarters · filed 2026-04-28 | $468.86M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $110.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $257.12M derived: sum of 2 quarters · filed 2026-02-24 | $291.44M derived: sum of 3 quarters · filed 2026-02-24 | $386.92M 10-K · filed 2026-02-24 |
| 2025-09-30 | $146.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $180.48M derived: sum of 2 quarters · filed 2025-10-28 | $275.95M 10-Q · filed 2025-10-28 | $297.95M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $34.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $129.79M 10-Q · filed 2025-07-29 | $151.79M derived: sum of 3 quarters · filed 2026-04-28 | $206.27M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $95.47M 10-Q · filed 2026-04-28 | $117.46M derived: sum of 2 quarters · filed 2026-04-28 | $171.94M derived: sum of 3 quarters · filed 2026-04-28 | $261.21M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $21.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $76.47M derived: sum of 2 quarters · filed 2026-02-24 | $165.74M derived: sum of 3 quarters · filed 2026-02-24 | $202.01M 10-K · filed 2026-02-24 |
| 2024-09-30 | $54.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $143.74M derived: sum of 2 quarters · filed 2025-10-28 | $180.02M 10-Q · filed 2025-10-28 | $240.84M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $89.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $125.54M 10-Q · filed 2025-07-29 | $186.36M derived: sum of 3 quarters · filed 2026-02-24 | $239.44M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $36.28M 10-Q · filed 2025-04-29 | $97.09M derived: sum of 2 quarters · filed 2026-02-24 | $150.18M derived: sum of 3 quarters · filed 2026-02-24 | $188.31M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $60.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $113.91M derived: sum of 2 quarters · filed 2026-02-24 | $152.04M derived: sum of 3 quarters · filed 2026-02-24 | $204.93M 10-K · filed 2026-02-24 |
| 2023-09-30 | $53.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $91.22M derived: sum of 2 quarters · filed 2024-10-29 | $144.12M 10-Q · filed 2024-10-29 | $206.92M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $38.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $91.03M 10-Q · filed 2024-07-25 | $153.83M derived: sum of 3 quarters · filed 2025-02-25 | $171.16M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $52.90M 10-Q · filed 2024-04-25 | $115.70M derived: sum of 2 quarters · filed 2025-02-25 | $133.03M derived: sum of 3 quarters · filed 2025-02-25 | $158.54M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $62.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $80.13M derived: sum of 2 quarters · filed 2025-02-25 | $105.64M derived: sum of 3 quarters · filed 2025-02-25 | $135.86M 10-K · filed 2025-02-25 |
| 2022-09-30 | $17.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $42.84M derived: sum of 2 quarters · filed 2023-11-02 | $73.06M 10-Q · filed 2023-11-02 | $132.85M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $25.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $55.73M 10-Q · filed 2023-08-01 | $115.52M derived: sum of 3 quarters · filed 2024-02-28 | $115.52M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $30.22M 10-Q · filed 2023-05-04 | $90.01M derived: sum of 2 quarters · filed 2024-02-28 | $90.01M derived: sum of 3 quarters · filed 2024-02-28 | $113.11M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $59.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $59.79M derived: sum of 2 quarters · filed 2024-02-28 | $82.89M derived: sum of 3 quarters · filed 2024-02-28 | $157.25M 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $23.10M derived: sum of 2 quarters · filed 2022-11-03 | $97.46M 10-Q · filed 2022-11-03 | $183.51M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $23.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $97.46M 10-Q · filed 2022-08-04 | $183.51M derived: sum of 3 quarters · filed 2023-03-02 | $393.72M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $74.36M 10-Q · filed 2022-05-05 | $160.41M derived: sum of 2 quarters · filed 2023-03-02 | $370.62M derived: sum of 3 quarters · filed 2023-03-02 | $478.39M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $86.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $296.26M derived: sum of 2 quarters · filed 2023-03-02 | $404.02M derived: sum of 3 quarters · filed 2023-03-02 | $430.21M 10-K · filed 2023-03-02 |
| 2020-09-30 | $210.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $317.97M derived: sum of 2 quarters · filed 2021-11-04 | $344.16M 10-Q · filed 2021-11-04 | $426.80M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $107.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $133.95M 10-Q · filed 2021-08-05 | $216.59M derived: sum of 3 quarters · filed 2022-02-24 | $349.24M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $26.19M 10-Q · filed 2021-05-06 | $108.83M derived: sum of 2 quarters · filed 2022-02-24 | $241.47M derived: sum of 3 quarters · filed 2022-02-24 | $333.15M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $82.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $215.28M derived: sum of 2 quarters · filed 2022-02-24 | $306.97M derived: sum of 3 quarters · filed 2022-02-24 | $488.77M 10-K · filed 2022-02-24 |
| 2019-09-30 | $132.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $224.33M derived: sum of 2 quarters · filed 2020-11-05 | $406.13M 10-Q · filed 2020-11-05 | $515.56M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $91.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $273.49M 10-Q · filed 2020-08-04 | $382.91M derived: sum of 3 quarters · filed 2021-02-25 | $601.82M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $181.81M 10-Q · filed 2020-05-04 | $291.23M derived: sum of 2 quarters · filed 2021-02-25 | $510.14M derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | $109.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $328.33M derived: sum of 2 quarters · filed 2021-02-25 | $402.01M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $218.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $292.58M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $73.68M 10-Q · filed 2019-08-13 |